Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05216770 · ClinicalTrials.gov registry record · Early Phase 1

Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor

A Early Phase 1 study of Tremor and Laryngeal Dystonia, sponsored by Massachusetts Eye and Ear Infirmary.

Recruiting
Registry status
Early Phase 1
Development phase
165
Enrollment target
1
Study location

NCT05216770 is a Early Phase 1 study of Tremor and Laryngeal Dystonia that is actively recruiting participants, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 165 participants, below the 571-participant average among 10 other Tremor trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05216770, a Early Phase 1 study of Tremor and Laryngeal Dystonia, is actively recruiting participants, sponsored by Massachusetts Eye and Ear Infirmary.

RECRUITING
Registry status
Early Phase 1
Development phase
165 participants
Enrollment target
1
Study location

Study Summary

The researchers will examine functional neural correlates that differentiate between laryngeal dystonia and voice tremor and contribute to disorder-specific pathophysiology using a cross-disciplinary approach of multimodal brain imaging.

Interventions

  • OTHER Brain imaging
  • DRUG Laryngeal sensory block with topical bupivacaine

Study Locations (1)

Massachusetts

  • Massachusetts Eye and Ear and University of California San Francisco - Boston

Trial Details

FieldValue
Enrollment Target 165 participants
Start Date 2022-03-24
Est. Completion 2027-08-31
Phase Early Phase 1

What the Registry Record Tells You About NCT05216770

The ClinicalTrials.gov registry entry for NCT05216770 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 571-participant average among 10 other Tremor trials with a reported enrollment target (71% lower). The listed sponsor is Massachusetts Eye and Ear Infirmary, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Tremor appearing as the primary indexed condition, and to 2 interventions - of which Brain imaging is the first listed.

NCT05216770 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05216770 about?

NCT05216770 is a clinical study titled "Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor". The researchers will examine functional neural correlates that differentiate between laryngeal dystonia and voice tremor and contribute to disorder-specific pathophysiology using a cross-disciplinary approach of multimodal brain imaging.

What is the current status of trial NCT05216770?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 165 participants. The study started on 2022-03-24. Estimated completion is 2027-08-31.

What conditions does trial NCT05216770 study?

This clinical trial studies the following conditions: Tremor, Laryngeal Dystonia, Spasmodic Dysphonia.

What interventions are being tested in trial NCT05216770?

The interventions under investigation include: Brain imaging (OTHER), Laryngeal sensory block with topical bupivacaine (DRUG).

Who is sponsoring clinical trial NCT05216770?

This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05216770 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tremor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.